Superior Planning, LLC’s Edgewise Therapeutics EWTX Stock Holding History

Superior Planning, LLC’s Portfolio EWTX Stock Details EWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.4K	Buy	+330	New	+$14K	0.01%	820

Other funds holding EWTX

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Tyro Capital Management Miami, Florida $564M AUM 72.37% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Superior Planning, LLC's EWTX Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Edgewise Therapeutics (EWTX) in Q3 2026: 330 shares worth $13.4K. The stake represents 0.01% of the portfolio and ranks #820 among its holdings.

123 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

Superior Planning, LLC held 330 shares of Edgewise Therapeutics worth $13.4K as of Q3 2026.
Edgewise Therapeutics was a new Superior Planning, LLC position in Q3 2026.
Edgewise Therapeutics made up 0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #820 holding.
123 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.